EP4121050A4 - Compositions polymorphes stables de bréquinar sodium et procédés d'utilisation et de fabrication de celles-ci - Google Patents

Compositions polymorphes stables de bréquinar sodium et procédés d'utilisation et de fabrication de celles-ci

Info

Publication number
EP4121050A4
EP4121050A4 EP21770978.1A EP21770978A EP4121050A4 EP 4121050 A4 EP4121050 A4 EP 4121050A4 EP 21770978 A EP21770978 A EP 21770978A EP 4121050 A4 EP4121050 A4 EP 4121050A4
Authority
EP
European Patent Office
Prior art keywords
manufacture
methods
brequinar sodium
stable polymorphic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21770978.1A
Other languages
German (de)
English (en)
Other versions
EP4121050A1 (fr
Inventor
Abdolsamad Tadayon
Ping Huang
Chaoyi DENG
Jinsuo YANG
Siyi Jiang
Qingqing LU
Lin Cui
Mo JIA
Xianjun You
David P. Hesson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clear Creek Bio Inc
Original Assignee
Clear Creek Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clear Creek Bio Inc filed Critical Clear Creek Bio Inc
Publication of EP4121050A1 publication Critical patent/EP4121050A1/fr
Publication of EP4121050A4 publication Critical patent/EP4121050A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP21770978.1A 2020-03-20 2021-03-19 Compositions polymorphes stables de bréquinar sodium et procédés d'utilisation et de fabrication de celles-ci Pending EP4121050A4 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US202062992720P 2020-03-20 2020-03-20
US202063020460P 2020-05-05 2020-05-05
US202063030677P 2020-05-27 2020-05-27
US202063043384P 2020-06-24 2020-06-24
US202063043382P 2020-06-24 2020-06-24
US202063043388P 2020-06-24 2020-06-24
US202063043386P 2020-06-24 2020-06-24
PCT/US2021/023350 WO2021189017A1 (fr) 2020-03-20 2021-03-19 Compositions polymorphes stables de bréquinar sodium et procédés d'utilisation et de fabrication de celles-ci

Publications (2)

Publication Number Publication Date
EP4121050A1 EP4121050A1 (fr) 2023-01-25
EP4121050A4 true EP4121050A4 (fr) 2024-04-17

Family

ID=77771654

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21770978.1A Pending EP4121050A4 (fr) 2020-03-20 2021-03-19 Compositions polymorphes stables de bréquinar sodium et procédés d'utilisation et de fabrication de celles-ci

Country Status (5)

Country Link
EP (1) EP4121050A4 (fr)
JP (1) JP2023518419A (fr)
AU (1) AU2021236757A1 (fr)
CA (1) CA3175964A1 (fr)
WO (1) WO2021189017A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023043830A1 (fr) * 2021-09-15 2023-03-23 Clear Creek Bio, Inc. Polythérapies pour traiter des infections virales

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2335503C2 (ru) * 2003-04-30 2008-10-10 Ниппон Синяку Ко., Лтд. Кристаллы сольвата производного хинолинкарбоновой кислоты
ES2768651T3 (es) * 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
CA2996632C (fr) * 2015-09-01 2023-10-17 Bayer Pharma Aktiengesellschaft Composes et methodes utiles pour le traitement ou la prevention de cancers hematologiques
US20190290634A1 (en) * 2018-03-26 2019-09-26 Clear Creek Bio, Inc. Compositions and methods for inhibiting dihydroorotate dehydrogenase
MX2021000143A (es) * 2018-06-22 2021-08-05 Ohio State Innovation Foundation Metodos y composiciones para la inhibicion de dihidroorotato deshidrogenasa.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HARWOOD L M ET AL: "Experimental organic chemistry - Principles and practice", 1 January 1989, EXPERIMENTAL CHEMISTRY - ORGANIC CHEMISTRY AND REACTION,, PAGE(S) 127 - 132, ISBN: 978-0-632-02016-4, XP003025361 *
See also references of WO2021189017A1 *
WU LEI-SHU ET AL: "The impact of crystallinity on brequinar sodium hygroscopicity", vol. 1, no. 1, 1 January 1996 (1996-01-01), pages 43 - 49, XP009552418, ISSN: 1083-7450, Retrieved from the Internet <URL:http://www.tandfonline.com/doi/full/10.3109/10837459609031417> [retrieved on 20080927], DOI: 10.3109/10837459609031417 *

Also Published As

Publication number Publication date
WO2021189017A1 (fr) 2021-09-23
CA3175964A1 (fr) 2021-09-23
AU2021236757A1 (en) 2022-10-13
EP4121050A1 (fr) 2023-01-25
JP2023518419A (ja) 2023-05-01

Similar Documents

Publication Publication Date Title
EP4054621A4 (fr) Compositions et procédés de remplacement d&#39;allèles d&#39;adn codé par l&#39;arn
EP4103662A4 (fr) Compositions de polissage et leurs procédés d&#39;utilisation
IL309073A (en) Enantiomeric entactogen compounds and methods of their use.
EP3976070A4 (fr) Compositions organoïdes façonnées et leurs procédés de fabrication
EP4127088A4 (fr) Compositions de polissage et leurs procédés d&#39;utilisation
EP4142740A4 (fr) Compositions et leurs méthodes d&#39;utilisation
EP4204506A4 (fr) Compositions de nettoyage et leurs procédés d&#39;utilisation
EP3930704A4 (fr) Compositions comprenant de l&#39;acide cinnamique et leurs procédés d&#39;utilisation
EP4164653A4 (fr) Formes morphiques de trilaciclib et leurs procédés de fabrication
GB202319843D0 (en) CAS13-based compositions and methods of use thereof
EP4121050A4 (fr) Compositions polymorphes stables de bréquinar sodium et procédés d&#39;utilisation et de fabrication de celles-ci
EP4139250A4 (fr) Procédé de préparation d&#39;iodosilanes et compositions à base de ceux-ci
EP4103663A4 (fr) Compositions de polissage et leurs procédés d&#39;utilisation
EP4121224A4 (fr) Compositions de nettoyage et leurs procédés d&#39;utilisation
IL304159A (en) A preparation containing bl-8040
EP4084802A4 (fr) Compositions d&#39;hydrogels et leurs procédés d&#39;utilisation
EP4181910A4 (fr) Compositions d&#39;oligosaccharides et procédés d&#39;utilisation
GB202012765D0 (en) Compositions and methods of production thereof
EP4081233A4 (fr) Composition et procédés de fabrication
EP4135687A4 (fr) Polycannabinoïdes, composés, compositions et procédés d&#39;utilisation
EP4054514A4 (fr) Compositions contenant des fenchols et procédés d&#39;utilisation
GB2593754B (en) Redox curable compositions and methods of manufacture thereof
EP4081047A4 (fr) Compositions d&#39;enzymes et leurs procédés de production
EP4125748A4 (fr) Système d&#39;indentation maculaire et ses procédés d&#39;utilisation et de fabrication
EP3920904A4 (fr) Compositions comprenant des cannabinoïdes et leurs procédés d&#39;utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220914

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031450000

Ipc: A61K0031470000

A4 Supplementary search report drawn up and despatched

Effective date: 20240320

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 215/52 20060101ALI20240314BHEP

Ipc: A61K 31/47 20060101AFI20240314BHEP